Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice

Ken Shirato, Shogo Sato, Madoka Sato, Yoko Hashizume, Kaoru Tachiyashiki, Kazuhiko Imaizumi

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Abstract

    We examined the effects of 6-week daily administration of an anabolic dose of a β2-agonist clenbuterol (1.0 mg/kg body weight/day) on the phagocytic capacity of splenic macrophages of 5-week-old male C57BL/6 J mice against Escherichia coli. After 24 h of cessation of clenbuterol or vehicle administration, splenic adherent cells were isolated and analyzed by flow-cytometry. The cells were separated into three subpopulations based on their size. The isolated cells included small cells, which expressed markedly higher levels of macrophage receptor with collagenous structure. Furthermore, these cells exhibited higher phagocytic capacity against E. coli when compared to other subpopulations. The phagocytic capacity of the small cells was clearly suppressed after clenbuterol administration. These results suggest that chronic utilization of clenbuterol as a doping drug impairs bacterial clearance mediated by highly phagocytic splenic macrophages.

    Original languageEnglish
    Title of host publicationPhysical Activity, Exercise, Sedentary Behavior and Health
    PublisherSpringer Japan
    Pages203-212
    Number of pages10
    ISBN (Print)9784431553335, 9784431553328
    DOIs
    Publication statusPublished - 2015 Jan 1

    Fingerprint

    Macrophages
    Phagocytosis
    Clenbuterol
    Escherichia coli
    Flow cytometry
    Doping (additives)
    Flow Cytometry
    Body Weight
    Pharmaceutical Preparations

    Keywords

    • Clenbuterol
    • Macrophage receptor with collagenous structure
    • Phagocytosis
    • Splenic macrophages
    • β<inf>2</inf>–agonist

    ASJC Scopus subject areas

    • Medicine(all)
    • Engineering(all)

    Cite this

    Shirato, K., Sato, S., Sato, M., Hashizume, Y., Tachiyashiki, K., & Imaizumi, K. (2015). Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice. In Physical Activity, Exercise, Sedentary Behavior and Health (pp. 203-212). Springer Japan. https://doi.org/10.1007/978-4-431-55333-5_17

    Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice. / Shirato, Ken; Sato, Shogo; Sato, Madoka; Hashizume, Yoko; Tachiyashiki, Kaoru; Imaizumi, Kazuhiko.

    Physical Activity, Exercise, Sedentary Behavior and Health. Springer Japan, 2015. p. 203-212.

    Research output: Chapter in Book/Report/Conference proceedingChapter

    Shirato, K, Sato, S, Sato, M, Hashizume, Y, Tachiyashiki, K & Imaizumi, K 2015, Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice. in Physical Activity, Exercise, Sedentary Behavior and Health. Springer Japan, pp. 203-212. https://doi.org/10.1007/978-4-431-55333-5_17
    Shirato K, Sato S, Sato M, Hashizume Y, Tachiyashiki K, Imaizumi K. Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice. In Physical Activity, Exercise, Sedentary Behavior and Health. Springer Japan. 2015. p. 203-212 https://doi.org/10.1007/978-4-431-55333-5_17
    Shirato, Ken ; Sato, Shogo ; Sato, Madoka ; Hashizume, Yoko ; Tachiyashiki, Kaoru ; Imaizumi, Kazuhiko. / Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice. Physical Activity, Exercise, Sedentary Behavior and Health. Springer Japan, 2015. pp. 203-212
    @inbook{1aef816771884780a6ebf56c2ba94a9d,
    title = "Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice",
    abstract = "We examined the effects of 6-week daily administration of an anabolic dose of a β2-agonist clenbuterol (1.0 mg/kg body weight/day) on the phagocytic capacity of splenic macrophages of 5-week-old male C57BL/6 J mice against Escherichia coli. After 24 h of cessation of clenbuterol or vehicle administration, splenic adherent cells were isolated and analyzed by flow-cytometry. The cells were separated into three subpopulations based on their size. The isolated cells included small cells, which expressed markedly higher levels of macrophage receptor with collagenous structure. Furthermore, these cells exhibited higher phagocytic capacity against E. coli when compared to other subpopulations. The phagocytic capacity of the small cells was clearly suppressed after clenbuterol administration. These results suggest that chronic utilization of clenbuterol as a doping drug impairs bacterial clearance mediated by highly phagocytic splenic macrophages.",
    keywords = "Clenbuterol, Macrophage receptor with collagenous structure, Phagocytosis, Splenic macrophages, β<inf>2</inf>–agonist",
    author = "Ken Shirato and Shogo Sato and Madoka Sato and Yoko Hashizume and Kaoru Tachiyashiki and Kazuhiko Imaizumi",
    year = "2015",
    month = "1",
    day = "1",
    doi = "10.1007/978-4-431-55333-5_17",
    language = "English",
    isbn = "9784431553335",
    pages = "203--212",
    booktitle = "Physical Activity, Exercise, Sedentary Behavior and Health",
    publisher = "Springer Japan",

    }

    TY - CHAP

    T1 - Effects of β2-agonist administration on bacterial phagocytosis by splenic macrophages in Mice

    AU - Shirato, Ken

    AU - Sato, Shogo

    AU - Sato, Madoka

    AU - Hashizume, Yoko

    AU - Tachiyashiki, Kaoru

    AU - Imaizumi, Kazuhiko

    PY - 2015/1/1

    Y1 - 2015/1/1

    N2 - We examined the effects of 6-week daily administration of an anabolic dose of a β2-agonist clenbuterol (1.0 mg/kg body weight/day) on the phagocytic capacity of splenic macrophages of 5-week-old male C57BL/6 J mice against Escherichia coli. After 24 h of cessation of clenbuterol or vehicle administration, splenic adherent cells were isolated and analyzed by flow-cytometry. The cells were separated into three subpopulations based on their size. The isolated cells included small cells, which expressed markedly higher levels of macrophage receptor with collagenous structure. Furthermore, these cells exhibited higher phagocytic capacity against E. coli when compared to other subpopulations. The phagocytic capacity of the small cells was clearly suppressed after clenbuterol administration. These results suggest that chronic utilization of clenbuterol as a doping drug impairs bacterial clearance mediated by highly phagocytic splenic macrophages.

    AB - We examined the effects of 6-week daily administration of an anabolic dose of a β2-agonist clenbuterol (1.0 mg/kg body weight/day) on the phagocytic capacity of splenic macrophages of 5-week-old male C57BL/6 J mice against Escherichia coli. After 24 h of cessation of clenbuterol or vehicle administration, splenic adherent cells were isolated and analyzed by flow-cytometry. The cells were separated into three subpopulations based on their size. The isolated cells included small cells, which expressed markedly higher levels of macrophage receptor with collagenous structure. Furthermore, these cells exhibited higher phagocytic capacity against E. coli when compared to other subpopulations. The phagocytic capacity of the small cells was clearly suppressed after clenbuterol administration. These results suggest that chronic utilization of clenbuterol as a doping drug impairs bacterial clearance mediated by highly phagocytic splenic macrophages.

    KW - Clenbuterol

    KW - Macrophage receptor with collagenous structure

    KW - Phagocytosis

    KW - Splenic macrophages

    KW - β<inf>2</inf>–agonist

    UR - http://www.scopus.com/inward/record.url?scp=84943273955&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84943273955&partnerID=8YFLogxK

    U2 - 10.1007/978-4-431-55333-5_17

    DO - 10.1007/978-4-431-55333-5_17

    M3 - Chapter

    SN - 9784431553335

    SN - 9784431553328

    SP - 203

    EP - 212

    BT - Physical Activity, Exercise, Sedentary Behavior and Health

    PB - Springer Japan

    ER -